Plasmalogen synthesis is regulated via alkyl‐dihydroxyacetonephosphate‐synthase by amyloid precursor protein processing and is affected in Alzheimer’s disease

Grimm, Marcus O. W.; Kuchenbecker, Johanna; Rothhaar, Tatjana L.; Grösgen, Sven; Hundsdörfer, Benjamin; Burg, Verena K.; Friess, Petra; Müller, Ulrike; Grimm, Heike S.; Riemenschneider, Mathias; Hartmann, Tobias

doi:10.1111/j.1471-4159.2010.07070.x

Cited by 98 publications

(98 citation statements)

References 70 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In line with these findings, it has been recently reported that differentiated PC12 cells, treated with the γ-secretase inhibitor DAPT, show an increase in ganglioside level in neuritic terminals [62], further strengthening that PS proteolytic activity alters ganglioside homeostasis. Additionally, we and others recently found that cleavage products of APP are involved in the regulation of several proteins and that this regulation is disturbed in absence of PS, in mutated PS or in AD [11,30,31,32,63,64,65]. Main focus was attended to the APP intracellular domain (AICD), which is released to the cytosol and discussed to be involved in gene transcription.…”

Section: Discussionmentioning

confidence: 99%

“…AICD was found to decrease gene expression of the catalytic subunit of serine-palmitoyl-CoA transferase (SPT) [31] and to down regulate the expression of GD3-synthase (GD3S), the key enzyme converting a- to b- series gangliosides [11]. Furthermore, AICD was reported to increase the expression level of the alkyl-dihydroxyacetone phosphate-synthase (AGPS), a rate limiting enzyme in plasmalogen synthesis [32], representing major brain lipids which are discussed to be altered in AD [66,67]. AICD was also found to suppress the transcription of lipoprotein receptor LRP1 [68].…”

Section: Discussionmentioning

confidence: 99%

“…Human post mortem brains and correspondent control brain samples were obtained from Brain-net (Munich, Germany) and have been described earlier [32]. Murine APP -/- brain material was obtained from U. Müller (Heidelberg, Germany) [33], conditional PS1/2 -/- mouse brains from J. Shen (Boston, USA) [34], APPswe mouse brains from H. Tanila (Kuopio, Finnland) and PSmutKI brains from T. Bayer (Göttingen, Germany) [35].…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

PS Dependent APP Cleavage Regulates Glucosylceramide Synthase and is Affected in Alzheimer's Disease

Grimm

Hundsdörfer

Grösgen

et al. 2014

Cell Physiol Biochem

Self Cite

View full text Add to dashboard Cite

Background: Gangliosides were found to be associated with Alzheimer's disease (AD). Here we addressed a potential function of γ-secretase (presenilin) dependent cleavage of the amyloid-precursor-protein (APP) in the regulation of ganglioside de novo synthesis. Methods: To identify a potential role of γ-secretase and APP in ganglioside de novo synthesis we used presenilin (PS) deficient and APP deficient cells and mouse brains, mutated PS as well as transgenic mice and AD post mortem brains. Changes in glucosylceramide synthase (GCS) activity were identified by incorporation of radiolabeled UDP-glucose in glucosylceramide, changes in gene expression via real-time PCR and Western blot analysis. Alterations in ganglioside levels were determined by thin layer chromatography and mass spectrometry. Results: We found that PS and APP deficiency, in vitro and in vivo, resulted in increased GCS gene expression, elevated enzyme activity and thus increased glucosylceramide and total ganglioside level. Using a specific γ-secretase inhibitor revealed that PS proteolytic activity alters ganglioside homeostasis. By the use of mutated PS causing early onset AD in cell culture and transgenic mice we found that GCS is increased in AD, further substantiated by the use of AD post mortem brains, suffering from sporadic AD. Conclusion: APP processing regulates ganglioside de novo synthesis and is affected in AD.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

PS Dependent APP Cleavage Regulates Glucosylceramide Synthase and is Affected in Alzheimer's Disease

Grimm

Hundsdörfer

Grösgen

et al. 2014

Cell Physiol Biochem

Self Cite

View full text Add to dashboard Cite

show abstract

“…More recently, the intercellular domain of APP was found to decrease the expression of alkyl-dihydroxyacetonephosphate synthase (AGPS), the rate-limiting enzyme in pPE biosynthesis [50]. In addition to modulating AGPS levels, AD pathogenesis could affect pPE levels in another way.…”

Section: Plasmalogen Ethanolaminesmentioning

confidence: 99%

Lipid Metabolism in Neurodegenerative Diseases

2012

View full text Add to dashboard Cite

“…The α-secretase cleaves APP within the Aβ domain, thus precluding the formation of Aβ peptides. The γ-secretase cleavage of βCTF/C99 and αCTF/C83 liberates the APP intracellular domain (AICD), which translocates to the nucleus and regulates gene expression [306][307][308][309][310].…”

Section: Proteolytic Processing Of App Amyloidogenic App Processingmentioning

confidence: 99%

Recent Understanding of the Molecular Mechanisms of Alzheimer?s Disease

Grimm¹,

Hartmann²

2011

J Addict Res Ther

Self Cite

View full text Add to dashboard Cite

Alzheimer's disease (AD) is the most common form of dementia in the elderly and is characterized in patients by an inexorably progression, causing problems with memory, thinking and behaviour. Currently 25 million people worldwide are estimated to be affected by AD with the highest number in North America, Latin America, Western Europe, China and the western pacific [1]. Epidemiological studies predict that the incidence of AD will increase due to increasing life expectancy to 42.3 million in 2020 and 81.1 million in 2040 [1,2], emphasizing AD as a major public health concern.The two main histopathological hallmarks of AD are extracellular amyloid plaques and intracellular neurofibrillary tangles in vulnerable brain regions like hippocampus and cortex [3]. The amyloid plaques, also called senile plaques, are mainly composed of amyloid-beta peptides (Aβ), most of which are 38 to 43 amino acids long [4]. Aβ peptides are generated by sequential processing of the amyloid precursor protein (APP), a large type-I transmembrane protein [5] that belongs to an evolutionary conserved protein family including beside APP, the APP-like protein 1 (APLP1) and 2 (APLP2) in mammals [6,7] with the Aβ domain to be unique to APP [8]. The second characteristic pathological hallmark of AD, the intracellular neurofibrillary tangles, consist of an abnormally phosphorylated form of the microtubule-associated protein tau [9]. In contrast to amyloid plaques, which accumulate extracellularly in the brains of AD affected individuals and have been long believed to cause neuronal damage and cell death, neurofibrillary tangles are found inside neurons and their branching points like axons and dendrites [10,11]. Proteolytic Processing of APP Amyloidogenic APP processingProteolytic processing of APP leading to Aβ peptides is a ubiquitous cellular process involving β-and γ-secretase activity (Figure 1). The first step in Aβ production is APP cleavage by β-secretase, generating the N-terminus of Aβ. BACE 1 (β-site APP cleaving enzyme, also called Asp2 or memapsin2) was identified as the major β-secretase, a membrane-bound protease that belongs to the pepsin family of aspartyl proteases [12][13][14]. Aβ generation is abolished in cultures of BACE1-deficient embryonic cortical neurons [15] and in BACE1 knock-out mice [16,17]. Whereas Luo and Roberds et al. [16,17] reported a normal phenotype of BACE1-deficient mice, more recent studies found severe phenotypic abnormalities in BACE1 knock-out mice [18], challenging BACE1 as safe drug target for AD. Furthermore, additional BACE1 substrates have been reported, suggesting a variety of BACE1 physiological functions. Identified substrates include proteins with important neuronal function, like the β2-subunit of the voltage-gated sodium channel (Navβ2) [19,20], important for normal action potential regulation and neuronal excitability, and neuregulin-1 [21,22], as ligand for members of the ErbB family of receptor-tyrosine kinases, involved in synapse formation, myelination of central and peripheral axon...

show abstract

Plasmalogen synthesis is regulated via alkyl‐dihydroxyacetonephosphate‐synthase by amyloid precursor protein processing and is affected in Alzheimer’s disease

Cited by 98 publications

References 70 publications

PS Dependent APP Cleavage Regulates Glucosylceramide Synthase and is Affected in Alzheimer's Disease

PS Dependent APP Cleavage Regulates Glucosylceramide Synthase and is Affected in Alzheimer's Disease

Lipid Metabolism in Neurodegenerative Diseases

Recent Understanding of the Molecular Mechanisms of Alzheimer?s Disease

Contact Info

Product

Resources

About